About this trial
This clinical trial aims to develop a predictive model for gastric cancer (GC) peritoneal metastasis and cachexia by integrating BUB1 gene data with radiological and pathological data using advanced deep learning techniques. The study will focus on utilizing imaging genomics (radiomics) and histopathological data to identify early biomarkers for peritoneal metastasis and cachexia in GC patients. By leveraging deep learning algorithms, the project seeks to improve the accuracy and reliability of predictions, enabling earlier intervention and personalized treatment strategies. The ultimate goal is to enhance clinical decision-making and prognosis prediction in GC patients with peritoneal metastasis and cachexia.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- BUB1-Integrated Deep Learning Model for Gastric Cancer Metastasis and Cachexia Prediction
Treatment groups
Locations
Sponsors and collaborators
Qun Zhao
Lead sponsor
Hebei Medical University
Sponsor institution